Top News: #MultipleSclerosis

Here are the top read news for #MultipleSclerosis:

imagSwitch to rituximab shows anti-inflammatory effect in relapsing-remitting MS:

Rituximab may be an attractive treatment option for patients with relapsing-remitting multiple sclerosis (MS), suggest phase II study findings showing its efficacy in controlling inflammatory activity: Read more



obese-teen-measuring-waistObesity and multiple sclerosis: Is there a causal relationship?:

Multiple sclerosis is an unpredictable condition of the central nervous system that ranges from mild to devastating; in people with the disease, communication between the brain and body is disrupted. However, the risk factors that cause the disease are poorly understood. Now, a new study investigates the link between obesity and multiple sclerosis: Read more


UMH_L_MSSleep@1x (1)In MS, Can Better Sleep Improve Cognition?:

People with multiple sclerosis often have trouble with memory, attention and mental processing. New research shows some of these issues could stem from sleep disorders: Read more



160609222439_1_540x360MS breakthrough: Replacing diseased immune system halts progression, allows repair:

An intensive procedure that completely wipes out the immune system and then regenerates a new one using blood stem cells can eliminate all signs of damaging brain inflammation in people with early, aggressive multiple sclerosis (MS), and facilitate lasting recovery, report scientists: Read more


logo3FDA approves Zinbryta to treat multiple sclerosis:

The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly: Read more